Literature DB >> 20578257

Hyperphosphatasia with seizures, neurologic deficit, and characteristic facial features: Five new patients with Mabry syndrome.

Miles D Thompson1, Marjan M Nezarati, Gabriele Gillessen-Kaesbach, Peter Meinecke, Roberto Mendoza-Londono, Roberto Mendoza, Etienne Mornet, Isabelle Brun-Heath, Catherine Prost Squarcioni, Laurence Legeai-Mallet, Arnold Munnich, David E C Cole.   

Abstract

Persistent hyperphosphatasia associated with developmental delay and seizures was described in a single family by Mabry et al. 1970 (OMIM 239300), but the nosology of this condition has remained uncertain ever since. We report on five new patients (two siblings, one offspring of consanguineous parents, and two sporadic patients) that help delineate this distinctive disorder and provide evidence in favor of autosomal recessive inheritance. Common to all five new patients is facial dysmorphism, namely hypertelorism, a broad nasal bridge and a tented mouth. All patients have some degree of brachytelephalangy but the phalangeal shortening varies in position and degree. In all, there is a persistent elevation of alkaline phosphatase activity without any evidence for active bone or liver disease. The degree of hyperphosphatasia varies considerably ( approximately 1.3-20 times the upper age-adjusted reference limit) between patients, but is relatively constant over time. In the first family described by Mabry et al. 1970, at least one member was found to have intracellular inclusions on biopsy of some but not all tissues. This was confirmed in three of our patients, but the inclusions are not always observed and the intracellular storage material has not been identified. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20578257     DOI: 10.1002/ajmg.a.33438

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

1.  The Coffin-Siris syndrome: a proposed diagnostic approach and assessment of 15 overlapping cases.

Authors:  Samantha A Schrier; Joann N Bodurtha; Barbara Burton; Albert E Chudley; Mary Anne D Chiong; Maria Gabriella D'avanzo; Sally Ann Lynch; Antonio Musio; Dmitriy M Nyazov; Pedro A Sanchez-Lara; Stavit A Shalev; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

2.  Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome.

Authors:  Yoshiko Murakami; Noriyuki Kanzawa; Kazunobu Saito; Peter M Krawitz; Stefan Mundlos; Peter N Robinson; Anastasios Karadimitris; Yusuke Maeda; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2012-01-06       Impact factor: 5.157

3.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.

Authors:  Peter M Krawitz; Michal R Schweiger; Christian Rödelsperger; Carlo Marcelis; Uwe Kölsch; Christian Meisel; Friederike Stephani; Taroh Kinoshita; Yoshiko Murakami; Sebastian Bauer; Melanie Isau; Axel Fischer; Andreas Dahl; Martin Kerick; Jochen Hecht; Sebastian Köhler; Marten Jäger; Johannes Grünhagen; Birgit Jonske de Condor; Sandra Doelken; Han G Brunner; Peter Meinecke; Eberhard Passarge; Miles D Thompson; David E Cole; Denise Horn; Tony Roscioli; Stefan Mundlos; Peter N Robinson
Journal:  Nat Genet       Date:  2010-08-29       Impact factor: 38.330

4.  PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.

Authors:  Peter M Krawitz; Yoshiko Murakami; Angelika Rieß; Marja Hietala; Ulrike Krüger; Na Zhu; Taroh Kinoshita; Stefan Mundlos; Jochen Hecht; Peter N Robinson; Denise Horn
Journal:  Am J Hum Genet       Date:  2013-04-04       Impact factor: 11.025

5.  Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain.

Authors:  János Hanics; János Barna; Jinsong Xiao; José Luis Millán; Caroline Fonta; László Négyessy
Journal:  Cell Tissue Res       Date:  2012-06-14       Impact factor: 5.249

6.  Chronic idiopathic hyperphosphatasia with unusual dental findings - A case report.

Authors:  Cheriya K Sreejan; Nair Gopakumar; Gogineni Subhas Babu
Journal:  J Clin Exp Dent       Date:  2012-12-01

7.  Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis.

Authors:  Alexej Knaus; Jean Tori Pantel; Manuela Pendziwiat; Nurulhuda Hajjir; Max Zhao; Tzung-Chien Hsieh; Max Schubach; Yaron Gurovich; Nicole Fleischer; Marten Jäger; Sebastian Köhler; Hiltrud Muhle; Christian Korff; Rikke S Møller; Allan Bayat; Patrick Calvas; Nicolas Chassaing; Hannah Warren; Steven Skinner; Raymond Louie; Christina Evers; Marc Bohn; Hans-Jürgen Christen; Myrthe van den Born; Ewa Obersztyn; Agnieszka Charzewska; Milda Endziniene; Fanny Kortüm; Natasha Brown; Peter N Robinson; Helenius J Schelhaas; Yvonne Weber; Ingo Helbig; Stefan Mundlos; Denise Horn; Peter M Krawitz
Journal:  Genome Med       Date:  2018-01-09       Impact factor: 11.117

Review 8.  Tissue-Nonspecific Alkaline Phosphatase in Central Nervous System Health and Disease: A Focus on Brain Microvascular Endothelial Cells.

Authors:  Divine C Nwafor; Allison L Brichacek; Ahsan Ali; Candice M Brown
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

9.  Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome.

Authors:  Alexej Knaus; Tomonari Awaya; Ingo Helbig; Zaid Afawi; Manuela Pendziwiat; Jubran Abu-Rachma; Miles D Thompson; David E Cole; Steve Skinner; Fran Annese; Natalie Canham; Michal R Schweiger; Peter N Robinson; Stefan Mundlos; Taroh Kinoshita; Arnold Munnich; Yoshiko Murakami; Denise Horn; Peter M Krawitz
Journal:  Hum Mutat       Date:  2016-05-19       Impact factor: 4.878

10.  A genome-wide imaging-based screening to identify genes involved in synphilin-1 inclusion formation in Saccharomyces cerevisiae.

Authors:  Lei Zhao; Qian Yang; Ju Zheng; Xuefeng Zhu; Xinxin Hao; Jia Song; Tom Lebacq; Vanessa Franssens; Joris Winderickx; Thomas Nystrom; Beidong Liu
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.